|
End-of-day quote
Korea S.E.
11/09/2026
|
5-day change | 1st Jan Change | ||
| 2,235.00 KRW | -5.10% |
|
0.00% | -2.83% |
Company Valuation: SCL Science Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 83,481 | 61,035 | 47,935 | 64,191 | 60,015 | 78,131 |
| Change | - | -26.89% | -21.46% | 33.91% | -6.5% | 30.19% |
| Enterprise Value (EV) 1 | 81,869 | 68,144 | 55,358 | 63,136 | 63,161 | 100,664 |
| Change | - | -16.77% | -18.76% | 14.05% | 0.04% | 59.38% |
| P/E | -27.4x | -12.1x | -7.57x | -11.1x | -16x | -19.2x |
| PBR | 6.45x | 6.06x | 3.74x | 3.4x | 3.87x | 3.2x |
| PEG | - | -0.2x | -0.6x | 0.4x | 0.4x | 2.96x |
| Capitalization / Revenue | 140x | 120x | 130x | 48.6x | 12.7x | 3.55x |
| EV / Revenue | 137x | 134x | 150x | 47.8x | 13.3x | 4.57x |
| EV / EBITDA | -25.9x | -17.6x | -14.4x | -19.6x | -25x | -285x |
| EV / EBIT | -22.1x | -15x | -12x | -15.7x | -17.3x | -29.6x |
| EV / FCF | -21.7x | -8x | -16.5x | -13.5x | -10.4x | -9.37x |
| FCF Yield | -4.62% | -12.5% | -6.07% | -7.41% | -9.65% | -10.7% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -151 | -249.3 | -282.6 | -200 | -128.4 | -120 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 596.2 | 507.3 | 369.8 | 1,322 | 4,737 | 22,011 |
| EBITDA 1 | -3,155 | -3,865 | -3,849 | -3,217 | -2,529 | -352.8 |
| EBIT 1 | -3,697 | -4,538 | -4,605 | -4,017 | -3,661 | -3,398 |
| Net income 1 | -3,047 | -5,029 | -5,972 | -5,026 | -3,730 | -3,934 |
| Net Debt 1 | -1,612 | 7,109 | 7,424 | -1,055 | 3,145 | 22,533 |
| Reference price 2 | 4,137.50 | 3,025.00 | 2,140.00 | 2,217.50 | 2,060.00 | 2,300.00 |
| Nbr of stocks (in thousands) | 20,177 | 20,177 | 22,399 | 28,947 | 29,134 | 33,970 |
| Announcement Date | 22/03/21 | 23/03/22 | 23/03/23 | 21/03/24 | 20/03/25 | 23/03/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 56.71M | |
| 18.1x | 4.19x | 9.84x | 0.5% | 78.04B | |
| -17.17x | 25.62x | -16.63x | -.--% | 57.48B | |
| 19.65x | 4.21x | 13.08x | 2.5% | 57.4B | |
| 34.47x | 11.73x | 22.49x | -.--% | 48.81B | |
| 20.54x | 4.54x | 12.95x | 0.71% | 45.5B | |
| 37.49x | 3.54x | 13.51x | -.--% | 32.08B | |
| 54.21x | 3.43x | 26.59x | -.--% | 24.62B | |
| 62.21x | 6.52x | 39.5x | -.--% | 20.77B | |
| 22.98x | 4.94x | 12.86x | -.--% | 15.75B | |
| Average | 28.05x | 7.64x | 14.91x | 0.41% | 38.05B | |
| Weighted average by Cap. | 21.98x | 8.49x | 11.46x | 0.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A246960 Stock
- Valuation SCL Science Inc.
Select your edition
All financial news and data tailored to specific country editions
